Management of Obesity in the National Health and Nutrition Examination Survey (NHANES), 2007-2008

Annals of Epidemiology

Volumn 22, Issue 5, 2012, Pages 349-353

  Samaranayake, Nithushi R ^a   Ong, Kwok L ^b   Leung, Raymond Y H ^a   Cheung, Bernard M Y ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b HEART RESEARCH INSTITUTE   (Australia)

Author keywords

Anti Obesity Drugs; Obesity; Orlistat; Phentermine; Sibutramine

Indexed keywords

NON PRESCRIPTION DRUG; PHENTERMINE; PRESCRIPTION DRUG; SIBUTRAMINE; TETRAHYDROLIPSTATIN;

ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; DEMOGRAPHY; DIET; DRUG RECALL; EXERCISE; FEMALE; HEALTH SURVEY; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; WEIGHT REDUCTION;

ADULT; ANTI-OBESITY AGENTS; CYCLOBUTANES; EXERCISE; FEMALE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; NUTRITION SURVEYS; OBESITY; PREVALENCE; UNITED STATES; WEIGHT LOSS;

EID: 84860246159     PISSN: 10472797     EISSN: 18732585     Source Type: Journal    
DOI: 10.1016/j.annepidem.2012.01.001     Document Type: Article

References (30)

1. Hubert H., Feinleib M., McNamara P., Castelli W. Obesity as an independent risk factor for cardiovascular disease: A 26- year follow-up of participants in the Framingham Heart Study. Circulation 1983, 67:968-977.
2. Lean M.E.J., Han T.S., Seidell J.C. Impairment of health and quality of life in people with large waist circumference. Lancet 1998, 351:853-856.
3. Hu F.B., Manson J.E., Stampfer M.J., Colditz G., Liu S., Solomon C.G., et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 2001, 345:790-797.
4. McGill H.C., McMahan C.A., Herderick E.E., Zieske A.W., Malcom G.T., Tracy R.E., et al. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation 2002, 105:2712-2718.
5. Li M., Cheung B.M. Pharmacotherapy for obesity. Br J Clin Pharmacol 2009, 68:804-810.
6. Wu T., Gao X., Chen M., van Dam R.M. Long-term effectiveness of diet-plus-exercise interventions vs. diet-only interventions for weight loss: A meta-analysis. Obes Rev 2009, 10:313-323.
7. Yaemsiri S., Slining M.M., Agarwal S.K. Perceived weight status, overweight diagnosis, and weight control among US adults: The NHANES 2003-2008 Study. Int J Obes 2011, 35:1063-1070.
8. Skender M.L., Goodrick G.K., Del Junco D.J., Reeves R.S., Darnell L., Gotto A.M., et al. Comparison of 2-year weight loss trends in behavioral treatments of obesity: Diet, exercise, and combination interventions. J Am Diet Assoc 1996, 96:342-346.
9. Hubacek J.A., Bohuslavova R., Kuthanova L., Kubinova R., Peasey A., Pikhart H., et al. The FTO gene and obesity in a large eastern European population sample: The HAPIEE study. Obesity (Silver Spring) 2008, 16:2764-2766.
10. Hubacek J.A. Eat less and exercise more-is it really enough to knock down the obesity pandemia?. Physiol Res 2009, 58:S1-S6.
11. Snow V., Barry P., Fitterman N., Qaseem A., Weiss K. Pharmacologic and surgical management of obesity in primary care: A clinical practice guideline from the American College of Physicians. Ann Intern Med 2005, 142:525-531. for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians.
12. Goldstein D. Beneficial health effects of modest weight loss. Intl J Obes Relat Metab Disord 1992, 16:397-415.
13. Wadden T.A., Berkowitz R.I., Womble L.G., Sarwer D.B., Phelan S., Cato R.K., et al. Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med 2005, 353:2111-2120.
14. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS): National Health and Nutrition Examination Survey questionnaire, examination protocol and laboratory protocol 2009 [cited 2010 1st October]; Available from: http://www.cdc.gov/nchs/nhanes/about_nhanes.htm.
15. Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497. National Cholesterol Eductional Program (NCEP) Expert Panel on Detection.
16. Drugs.com [Internet]. Sibutramine information from [English] [Updated 1st October 2010; cited on 5th October 2010]; Available from: Accessed January 16, 2012. http://www.drugs.com/pro/meridia.html.
17. Drugs.com [Internet]. Orlistat information from [English] [Updated 1st October 2010; cited on 5th October 2010]; Available from: Accessed January 16, 2012. http://www.drugs.com/xenical.html.
18. Drugs.com [Internet]. Phentermine information from [English] [Updated 1st October 2010; cited on October 2010]; Available from: Accessed January 16, 2012. http://www.drugs.com/phentermine.html.
19. Kaplan L.M. Pharmacologic therapies for obesity. Gastroenterol Clin North Am 2010, 39:69-79.
20. Batsis J.A., Nieto-Martinez R.E., Lopez-Jimenez F. Metabolic syndrome: From global epidemiology to individualized medicine. Clin Pharmacol Ther 2007, 82:509-524.
21. James W.P., Caterson I.D., Coutinho W., Finer N., Van Gaal L.F., Maggioni A.P., et al. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med 2010, 363:905-917.
22. Davidson M.H., Hauptman J., DiGirolamo M., Foreyt J.P., Halsted C.H., Heber D., et al. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat. JAMA 1999, 281:235-242.
23. King D.E., Mainous A.G., Carnemolla M., Everett C.J. Adherence to healthy lifestyle habits in US adults, 1988-2006. Am J Med 2009, 122:528-534.
24. National Institute of Health (NIH). National Heart, Lung and Blood Institute (NHLBI). The Practical Guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. 2000 [cited 2010 1st October]; Available from Accessed January 16, 2012. http://www.nhlbi.nih.gov/guidelines/obesity/practgde.htm.
25. National Health and Medical Research Council (NHMRC). Clinical practice guidelines for the management of overweight and obesity in adults. 2003. [cited 2010 1st October]; Available from Accessed January 16, 2012. http://www.health.gov.au/internet/main/publishing.nsf/Content/obesityguidelines-guidelines-adults.htm.
26. Shah K., Villareal D.T. Combination treatment to CONQUER obesity?. Lancet 2011, 377:1295-1297.
27. Li M.F., Cheung B.M.Y. Rise and fall of anti-obesity drugs. World J Diabetes 2011, 2:19-23.
28. Huntington M.K., Shewmake R.A. Anti-obesity drugs: Are they worth it?. Future Med Chem 2011, 3:267-269.
29. Mosca L., Jones W.K., King K.B., Ouyang P., Redberg R.F., Hill M.N. Awareness, perception, and knowledge of heart disease risk and prevention among women in the United States. American Heart Association Women's Heart Disease and Stroke Campaign Task Force. Arch Fam Med 2000, 9:506-515.
30. Pillitteri J.L., Shiffman S., Rohay J.M., Harkins A.M., Burton S.L., Wadden T.A. Use of dietary supplements for weight loss in the United States: Results of a national survey. Obesity 2008, 16:790-796.